Stories from MedEsthetics
Thursday, December 4, 2014 - 14:24
A Phase 3 clinical trial, called AMAGINE-2, evaluating three doses of brodalumab (Amgen/AstraZeneca) in patients with moderate to severe plaque psoriasis successfully met its key primary and secondary endpoints when compared to Stelara (ustekinumab) and placebo at week 12. Brodalumab, a human monoclonal antibody, targets and binds to the interleukin-17 (IL-17) receptor and blocks several IL-17 cytokines (A, F and A/F) from binding there, inhibiting inflammation. It is also being investigated for the treatment of psoriatic arthritis and asthma. No, don't share this with BeautyEtcArticle free...
Thursday, December 4, 2014 - 14:21
Deck: Byline: The American Academy of Dermatology (AAD) is seeking nominees for Assistant Secretary-Treasurer. Applicants must be active AAD members with significant administrative and financial management experience, and they must be available to attend the 2015 Annual Meeting in San Francisco. Candidates should be prepared to serve a total of six years: three years as Assistant Secretary-Treasurer and three years as Secretary-Treasurer. No, don't share this with BeautyEtcArticle free tagging: American Academy of DermatologyArticles: News
Wednesday, November 26, 2014 - 08:19
Valeant Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for ONEXTON Gel (clindamycin phosphate and benzoyl peroxide, 1.2%/3.75%), for the once-daily treatment of comedonal (non-inflammatory) and inflammatory acne in patients 12 and older. No, don't share this with BeautyEtcArticle free tagging: acneValeantbenzoyl peroxideclindamycinArticles: News
Wednesday, November 26, 2014 - 08:17
A new topical product featuring a combination of retinoids offers results comparable to hydroquinone in patients with facial melasma. Maria Teresa Truchuelo MD, PhD, Natalia Jimenez, MD, and Pedro Jaen, MD, PhD, of the dermatology department at University Hospital Ramon y Cajal in Madrid, Spain, performed a prospective, double-blind, vehicle-controlled, and randomized study in 30 patients with melasma. Sibjects applied the combination retinoid product on one side of their faces and the vehicle on the other. Product was applied twice daily for three months. No, don't share this with...
Wednesday, November 26, 2014 - 08:15
The United States Congress has passed the Sunscreen Innovation Act (H.R. 4250/S. 2141), which gives the Food and Drug Administration (FDA) the authority to prioritize the review and approval of more effective sunscreen ingredients that have been available to consumers outside the U.S. for several years.Yes, share this item with BeautyEtcArticle free tagging: antiagingsunscreenSkin CancerArticles: ArticlesSkin CareNews
Friday, November 21, 2014 - 09:18
The results of a retrospective review presented at the American Society for Dermatologic Surgery (ASDS) 2014 Annual Meeting show that repeated Botox Cosmetic treatment over many years is safe and effective. Furthermore, botulinum toxin injections can be safely used in conjunction with other aesthetic treatments. No, don't share this with BeautyEtcArticle free tagging: ASDS Annual MeetingstudyArticles: News
Friday, November 21, 2014 - 09:14
Deck: Byline: Tom Rohrer, MD, has been appointed vice president of the American Society for Dermatologic Surgery (ASDS). Dr. Rohrer is a physician at SkinCare Physicians in Chestnut Hill, Massachusetts, and adjunct associate professor of dermatology at Brown University in Rhode Island. He has previously received the 2010 ASDS President’s Award and has been an active member for nearly 20 years. No, don't share this with BeautyEtcArticle free tagging: American Society for Dermatologic SurgeryArticles: News
Friday, November 21, 2014 - 09:11
Deck: Byline: Dupilumab, a fully human monoclonal antibody, received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) to treat moderate to severe atopic dermatitis in adults for whom topical prescriptions do not work or are not an option. Co-developed by Regeneron and Sanofi, dupilumab blocks signaling from IL-4 and IL-13—the key cytokines responsible for the Th2 immune response that is understood to be a crucial pathway in allergic inflammation. It’s also being evaluated for the treatment of asthma and chronic sinusitis with nasal polyposis.No, don'...
Friday, November 14, 2014 - 12:21
Deck: Byline: The Allied Professionals Association (APA), a national spa and salon insurance group, has established a new Technology division that will bring innovative and patented equipment and treatments to the market. They are currently seeking a national VP to lead the expansion, as well as regional distributors. Candidates who are interested in applying can contact Ken at 800.444.7546, firstname.lastname@example.org. No, don't share this with BeautyEtcArticle free tagging: Allied Healthhelp wantedaesthetic technologyArticles: News
Friday, November 14, 2014 - 12:12
Deck: Byline: The energy output of aesthetic lasers can fluctuate significantly during treatment, which may explain variances in outcomes seen by providers, say Tim S. Lister, MD, and Mark P. Brewin of the Salisbury Laser Clinic in Salisbury, Wilshire, UK. For their study, “Variations in Laser Energy Outputs Over a Series of Simulated Treatments” (British Journal of Dermatology, November 2014), Lister and Brewin recorded the energy and pulse time data of seven laser systems using a pyroelectric measurement head with an optical diffuser and associated meter.No, don't share this with...
Friday, November 7, 2014 - 09:32
Main Image: A panel of Canadian dermatologists reviewed the role of antibiotics and their resistance in the treatment of mild to moderate acne vulgaris in an effort to reach a consensus on treatment guidelines. The study by Charles W. Lynde, MD, FRCPC, and Anneke Andriessen, PhD of the University of Toronto, was published in the Journal of Drugs in Dermatology (November 2014). The authors convened an expert panel of dermatologists and asked them to fill out a survey on their current practices and conducted a literature review using PubMed, Cochrane Library, Medline and EMBASE.No, don't...
Friday, November 7, 2014 - 09:29
LumiHeal, a topical photo-converter gel from KLOX Technologies, has received CE mark approval in Europe as a Class 2b medical device for the treatment of acute and chronic wounds. The gel is part of KLOX’s noninvasive BioPhotonic platform, which promotes wound healing by combining the photo-converter topical with a multi-LED light to stimulate the synergistic effects of oxidants and photons. No, don't share this with BeautyEtcArticle free tagging: LumiHealKLOX TechnologiesArticles: News
Friday, November 7, 2014 - 09:25
Michael Brower is the new chief financial officer of skincare product developer Sente. Brower previously served as chief financial and operations officer of LifeSaver, a southern California company that develops saliva diagnostic testing, and eyewear technology company Gunar Optiks. No, don't share this with BeautyEtcArticle free tagging: SenteArticles: News
Wednesday, November 5, 2014 - 13:01
Main Image: Osmosis Harmonized Water UV Neutralizer is a nontoxic and chemical-free potable supplement that offers UV protection. This purified water is imprinted with wave patterns that then vibrate on the skin to cancel out approximately 97% of UVA and UVB rays. Available in tan-enhancing and non-tan-enhancing formulas. Contact: 877.777.2305, www.osmosisskincare.com. No, don't share this with BeautyEtcArticles: ProductsArticle free tagging: Osmosissupplementsskin care
Wednesday, November 5, 2014 - 12:20
Main Image: The CEGA 30+Ferulic line from Young Pharmaceuticals fights photo-aging and conditions skin with a combination of vitamins C and E and hydroxy acids. When used in combination with retinoids, the hydroxy acids and vitamin C enhance the penetration and effects of the retinoids. Contact: 800.874.9686, www.youngpharm.com. No, don't share this with BeautyEtcArticles: ProductsArticle free tagging: Young PharmaceuticalsCEGA 30ferulic
Wednesday, November 5, 2014 - 12:17
Main Image: The redesigned Regenica Skin Care System from Suneva Medical features three products: Renew SPF 15, antiaging Replenishing Crème, and Repair Complex to accelerate skin renewal. The entire line uses a unique growth factor formula to stimulate collagen and elastin production for improved texture and firmness. Contact: 877.343.6422, www.regenica.com. No, don't share this with BeautyEtcArticles: ProductsArticle free tagging: Suneva MedicalSPF
Wednesday, November 5, 2014 - 12:14
Main Image: Valmont Prime B-Cellular, designed for use between a toner and moisturizer, rejuvenates skin with a combination of peptides, urea-lactic acid, allantoin and hyaluronic acid. The serum was developed to sustain skin’s natural elasticity while protecting against damage, and is ideal for sensitive and/or dry skin. Contact: 800.447.8800, www.boutiquevalmont.com/us. No, don't share this with BeautyEtcArticles: ProductsArticle free tagging: Valmont
Wednesday, November 5, 2014 - 12:11
Main Image: MD Complete Dark Spot Remover fades dark spots and sun damage, and brightens overall skin tone. Active ingredient hydroquinone helps correct hyperpigmentation; vitamins B, C and E stimulate collagen production; black raspberry and pomegranate fruit extracts even out skin tone; and soothing allantoin calms the skin. Contact: 800.260.2250,www.mdcompleteskincare.com. No, don't share this with BeautyEtcArticles: ProductsArticle free tagging: skin careMD Complete